Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 703 (USA) (Dr. Okafor)
· consented 2013-03-16
Adverse events
3
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild DECREASED APPETITE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-04 (study day 50.0); relationship: POSSIBLE
moderate
assessed
2026-08-18
Moderate DECREASED APPETITE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-04 (study day 50.0); relationship: POSSIBLE
mild
assessed
2026-08-18
Mild DISORIENTATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-04-02 (study day 18.0); relationship: REMOTE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.